Novel 1,4-Dihydropyridine Derivatives as Mineralocorticoid Receptor Antagonists.
Ontology highlight
ABSTRACT: The mineralocorticoid receptor (MR) belongs to the steroid receptor subfamily of nuclear receptors. MR is a transcription factor key in regulating blood pressure and mineral homeostasis. In addition, it plays an important role in a broad range of biological and pathological conditions, greatly expanding its interest as a pharmacological target. Non-steroidal MR antagonists (MRAs) are of particular interest to avoid side effects and achieve tissue-specific modulation of the receptor. The 1,4-dihydropyridine (1,4-DHP) ring has been identified as an appropriate scaffold to develop non-steroidal MRAs. We report the identification of a novel series of 1,4-DHP that has been guided by structure-based drug design, focusing on the less explored DHP position 2. Interestingly, substituents at this po
SUBMITTER: Perez-Gordillo FL
PROVIDER: S-EPMC9917360 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA